PUBLICATIONS

• Klimo P, Ibrahim EM. Anaphylactic reaction to methotrexate used in high-doses as an adjutant treatment of osteogenic sarcoma. Cancer Treat Reports; 65: 7-8, 1981.
• Leahy M F, Ibrahim EM, Worth AJ. Primary hepatic lymphoma: Two case reports and a review of the literature. Medical and Pediatric Oncology; 10: 575-581, 1982.
• Silver HB, Ibrahim EM, Evers JA, Thomas JW, Murry RN, Spinelli JJ. Adjutant BCG immunotherapy for Stage I and II malignant melanoma. Canadian Medical Association Journal; 128: 1291-l 295, 1983.
• Ibrahim AW, Ibrahim EM, Mitry N, Abdul Satir A, Kuppa A. Spinal cord compression due to intrathoracic extramedullary hematopoiesis in homozygous thalassemia. Journal of Neurology, Neurosurgery, and Psychiatry; 46: 780-782, 1983.
• Ibrahim EM, Al-Idrissi HY, Al-Faraj A, Al-Tamimi D, Perry W. Situs inversus totalis with embryonal cell carcinoma of ovaries. Gynecologic Oncology; 18: 270-273, 1984.
• Ibrahim EM, Anim JT, Al-Idrissi HY, Al-Mohaya S, Al-Dossary J,  Grant CS.       Abdominal tuberculosis: a frequent diagnostic challenge. Annals of Tropical  Medicine and Parasitology; 79: 163-218, 1985.
• Al-Idrissi HY, Ibrahim EM, Abdel Satir A, Satti MB, Al-Kasem S, Al-Qurain A.Primary hepatocellular carcinoma in the Eastern Province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycine, and mitornycin-C. Hepatogastroenterology; 31 (1): 8-10, 1985.
• Ibrahim EM, Satti MB, Al-Idrissi HY, Hegazi M, Magbool G, Al-Qurain A. Oral cancer in Saudi Arabia: the role of Alqat and Alshamma. Cancer Detection and  Prevention; 9: 215-218, 1986.
• Ibrahim AW, Satti MB, Ibrahim EM. Extraspinal meningioma:  Case report. Journal of Neurosurgery; 64: 328-330, 1986.
• Al-Freihi H, Al-Idrissi HY, Al-Qurain A, Al-Hamdan A, Ibrahim EM. The pattern of colonic disease in the Eastern Province of Saudi Arabia. Journal of Tropical Medicine and Hygiene; 89: 23-27, 1986.
• Ibrahim EM, Al-Idrissi HY, Ibrahim AW, Absood J,  Al-Dossary E, Jammaa A, Al-Ethan S, Eliopoulos A. Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy. European Journal of Cancer and Clinical Oncology; 22: 283-288, 1986.
• Ibrahim EM, Satti M B, Al-Idrissi HY, Satir Ali, Al-Mohaya SA, Qurain A, Al-Freihi H, Absood GH. Combination chemotherapy only for Stage II non-Hodgkin's lymphoma. European Journal of Cancer and Clinical Oncology; 22: 199-203, 1986.
• Ibrahim AW, Farag H, Naguib M, Ibrahim EM. Neuropithelial (colloid) cyst of  the third ventricle in identical twins. Journal of Neurosurgery; 65: 401-403, 1986.
• Al-Freihi H, Al-Mohaya S, Al-Mohsen MF, Ibrahim EM, Al-Sohaibani MO, Twum-Danso K, Al-Idrissi H. Brucellosis in Saudi Arabia: Diverse manifestations of an important cause of pyrexial illness. Annals of Saudi Medicine; 6: 95-l00, 1986.
• Al-Nahdy M, Al-Mohaya S, Ibrahim EM, Al-Idrissi HY. Prevalence of allergic       conditions in an outpatient population in the Eastern Province of Saudi Arabia. Folia Allergol Immunol Clin; 33: 453-459, 1986.
• Ibrahim EM, Al-Idrissi HY, Al-Mohaya S, Larbi EB, Al-Nahdy MS, Al-Hassan AY, Al-Mulhim FA, Al-Dossary J. Chest roentgenography in medical emergency. Annals of Saudi Medicine; 7: 57-61, 1987.
• Al-Freihi H, Al-Mohaya S, Ibrahim EM, Al-Idrissi HY, Barish E. Extrapulmonary tuberculosis. Diverse manifestations and diagnostic challenge. East African Medical Journal; 64: 295-302, 1987.
• Al-Idrissi HY, Satti MB, Al-Qurain A, Ibrahim EM, Al-Zamil F. Granulomatous oesophagitis: A case of tuberculosis limited to the esophagus. Annals of Tropical Medicine and Parasitology; 81 (2): 129-l33, 1987.
• Taha SA, Satti MB, Mitry NF, Al-Idrissi HY, Ibrahim EM.  Giant bladder diverticulum: An unusual presentation. British Journal of Urology; 59: 189-l90, 1987.
• Ibrahim EM, Al-Sohaibani M, Al-Suleiman SA, Satti MB, Al-Mulhim FA,  Qaddura F. Tuberculosis of the pancreas: A rare cause of obstructive jaundice and portal hypertension. Tropical Gastroenterology; 8 (3): 167-l72, 1987.
• Al-Nahdy M, Omer MS, Ibrahim EM, Al-Idrissi HY. Skin testing in an allergy affected population of Saudi Arabia. Allergie et Immunologie; 19 (4): 167-l71,  1987.
• Luqman W, Ibrahim EM. The outcome for some methods of evaluation of clinical students. Moteria Medica Polona; Fasc. 1 (6): 60-61, 1987.
• Al-Idrissi HY, Ibrahim EM, Abdullah KA, Ababtain WA, Boukhary HA, Macauly HMK. Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide, and diphenhydramine. British Journal of Cancer; 57: 308-312, 1988.
• Ibrahim EM, Satti MB, Naguib M, Absood GH, Al-Mulhim FA, Al-Ghassab G.      Hepatocellular carcinoma in Saudi Arabia: Evaluation of prognostic factors. Annals of Saudi Medicine; 8 (5): 329-335, 1988.
• Ibrahim EM, Satti MB, Al-Idrissi, Al-Mulhim FA, Absood GH, Jabar AA. Non-Hodgkin's lymphoma in Saudi Arabia: Analysis of prognostic factors and therapy outcome of combination chemotherapy only, for  both localized and advanced disease. European Journal of Cancer and Clinical Oncology; 24 (3): 391-401, 1988.
• Ibrahim EM, Al-Freihi H, Ryhan TI, Al-Sohaibani MO. Comparative study of students' performance at a premedical, preclinical, and clinical levels in a medical  school. Annals of Saudi Medicine; 8 (6): 481-484, 1988.
• Al-Qurain A, Satti MB, Al-Idrissi HY, Ibrahim EM, Al-Freihi H, Al-Hamdan AR, Al-Dossary J, Abdel Hadi M. Digestive tract malignancies in the Eastern Province of Saudi Arabia: An analysis of 158 patients. Cancer Detection and Prevention; 11: 331-336, 1988.
• Al-Qurain A, Ibrahim EM, Al-Ghassab G, Al-Mohana F, Baris 1. Use of flexible fiberoptic bronchoscopy in pulmonary diseases: Analysis of outcome and prediction of clinically useful studies. Indian J Chest Diseases and Allied Sciences; 30 (3): f 67-l 75, 1988.
• Ibrahim EM, Al-Mohaya SA, Al-Idrissi HY, Al-Jasser HH, Al-Fhaid SA, Ibrahim FAS. Clinical usefulness of predicted creatinine clearance in cancer patients  receiving cisplatin therapy. Annals of Saudi Medicine; 9 (5): 439-442, 1989.
• Al-Nahdy MS, Ibrahim EM. The prevalence of allergic disorders in Saudi Arabia: preliminary analysis based on surveying 300 individuals. Allergie and Immunologie; June, 241-242, 1989.
• Ibrahim EM, Uwaydah A, Al-Mulhim F, Ibrahim AW, Al-Hassan AY. Tuberculosis in patients with malignant disease. Indian Journal of Cancer; 26: 53-57, 1989.
• Sadat-Ali M , Ibrahim EM. Malignant bone tumors in pregnancy. Indian J of Cancer; 26: 151-l 55, 1989.
• Ibrahim EM, Al-Idrissi HY, Al-Mulhim FA, El-Hassan AY, Al-Khatti AA, Al-Khatib RI. The impact of routine chest radiography on the management of febrile neutropenic adult cancer patients. The Cancer Journal; 2 (11): 395-399,1989.
• Ibrahim EM, Al-Idrissi HY. MECOP-B in the management of non-Hodgkin's lymphoma: Preliminary analysis of prognostic factors and total dose-intensity. The Cancer Journal; 2 (12): 444-449, 1989.
• Ibrahim AWM, Chowdhary UM, Ammar A, Ibrahim EM. The outcome of head injuries: the Saudi Experience. Nagoya J Med Sci; 51: 1-6, 1989.
• Al-Freihi H, Al-Qurain A, Al-Gindan Y, Ibrahim EM, Satti MB, Twum-Danso K, Al-Idrissi HY. Al-Ghassab G, Al-Hamdan A. Cambylobacter pylori in patients undergoing upper gastrointestinal endoscopy. Hepatogastroenterology; 36: 409-542, 1989.
• Satti MB, Abu Melha A, Sohaibani MO, Sowayan S, Al-Qurain A, Ibrahim EM. Splenic foam cells: a clinico-pathologic analysis of 92 splenectomized patients Acta Hematologica; 83: 9-l 5, 1990.
• Al-Gindan YM, Al-Qurain A, Ibrahim EM, Al-Freihi H, Al-Mohsen MF, Hussein A, Saied 1, Al-Ghassab G, Al-Mohana F. Acute myocardial infarction in the Eastern Province of Saudi Arabia: retrospective study of 264 patients. Annals of Saudi Medicine; 10 (2): 129-l 36, 1990. 39.    El-Hassan AY, Al- Mulhim FA, Ibrahim EM, Al-Awami M. Retrospective appraisal of 300 consecutive mammographic studies. Annals of Saudi Medicine; 10 (3): 285-290, 1990.
• Ibrahim EM. Late relapse of Hodgkin's disease after 25 years. Indian Journal Cancer; 27: 17-l 9, 1990.
• Satti MB, Twum-Danso K, Al-Freihi M, Ibrahim EM, Al-Gindan Y, Al-Qurain A, Al-Ghassab G, Al-Hamdan A, Al-Idrissi HY. Helicobacter pylori-associated upper gastrointestinal disease in Saudi Arabia: A pathologic evaluation of 298 endoscopic biopsies from 201 consecutive patients. American Journal of Gastroenterology; 85 (5): 527-534, 1990.
• Al-Sohaibani MO, Satti MB, Ibrahim EM, Al-Sowayan S. Histologic patterns of            lymphadenopathy in the Eastern Province of Saudi Arabia. Annals Saudi  Medicine; 10 (5): 516-520, 1990.
• Satti MB, Al-Freihi H, Ibrahim EM, Abu-Melha A, Al-Ghassab G, Al-Idrissi HY, Al-Sohaibani MO. Hepatic granuloma in Saudi Arabia: A clinicopathologic study of 59 cases. American Journal of Gastroenterology; 85 (6): 669-674, 1990.
• Ibrahim EM. Pattern and prognosis of breast cancer at a referral center in Saudi      Arabia. Breast Disease; 3: 187-l 98, 1990.
• Ibrahim EM, Al-Idrissi HY, Al-Khatti AA, Al-Faraj AA, Al-Gindan Y, Al-Khatib RI, Al-Kharouf JA. Piperacillin combined with aminoglycoside for empirical therapy of febrile granulocytopenic cancer patients. Cancer Therapy and Control; 1: 205-211, 1990.
• Ibrahim EM, Satti MB, Koreich OM, Al-Uqali 1, Al-Mulhim FA. Hodgkin's disease involving the urinary bladder. Annals of Saudi Medicine; 11(3): 349-351, 1991.
• Ibrahim EM, Al-Idrissi HY, Al-Freihi HM, Al-Gindan YM. Evaluation of students performance and examination procedures in final certifying examinations in internal medicine (1982-l988). Annals Saudi Medicine; 11(3): 325-330, 1991.
• Ibrahim EM. Pattern and prognosis of breast cancer: data from the Eastern Province of Saudi Arabia. Saudi Medical Journal; 12(3): 227-231, 1991.
• Al-Idrissi HY, Larbi E, Ibrahim EM, Al-Freihi HM, Al-Mohaya SA, Al-Jasser H, Sukkar H. A randomized double-blind cross over study of nifedipine and captopril in mild and moderately severe hypertension in Saudis. Current Therapeutic Research; 49(3): 340-350, 1991.
• Ibrahim EM, Al-Muhana FA, Al-Jishi F, Saied I, Al- FM, Al-Idrissi HY, Al-Khadra AH, Al-Shehabi AF. Public knowledge, misperceptions and attitude about cancer in Saudi Arabia. Annals of Saudi Medicine;  11(5), 518-523, 1991.
• Al-Idrissi HY, Ibrahim EM. Hodgkin's disease in adults in Saudi Arabia: Clinical features, prognostic factors, and an analysis of therapy outcome of combination chemotherapy only for both localized and advanced disease. International Journal of Cancer; 47, 822-826, 1991.
• Ibrahim EM, Al-Idrissi HY, Al-Khadra AH, Kurashi NY, Al-Jishi FM, Saied 1, Al-Mohanna FA, Al-Shehabi AF. Women's knowledge about and attitude toward breast cancer in a developing country: implications for program interventions Results based on interviewing 500 women in Saudi Arabia. Journal of Cancer  Education; 6 (2), 73-81, 1991.
• Al-Freihi HM, Al-Hamdan A, Al-Qurain A, Al-Gindan YM, Ibrahim EM, Al-Ghassab G, Nabi HI. A single nocturnal dose of famotidine for the treatment of duodenal ulcer: evaluation of efficacy and safety. Tropical Gastroenterology, 12(2): 77-82, 1991.
• Higazzy MM, Ibrahim EM. The pattern and outcome of burn injuries at a burn unit in Saudi Arabia: retrospective analysis of consecutive 501 patients. Annals of Saudi Medicine; 11(3): 255-259, 1991.
• Kurashi NY, Al-Hamdan A, Ibrahim EM, Al-Idrissi HY, Al-Bayari TH. Community-acquired acute bacterial and atypical pneumonia in Saudi Arabia: Retrospective analysis of 567 episodes. Thorax, 47, 115-l18, 1992.
• Al-Khadra A, Muhanna F, Ibrahim EM. Patients' knowledge of hypertension and its management. Journal of Saudi Heart Association, 3 (3), 106-109, 1991.
• Al-Ghamdi MS, Ibrahim EM, Al-Idrissi HY, Al-Khattii AA, Al-Faraj A. Antiemetic efficacy of cimetidine. Randomized, double-blind, crossover study with dexamethasone in cancer patients receiving emetogenic chemotherapy. Annals of Oncology, Vol. 2, 517-518, 1991.
• El-Hassan AY, Ibrahim EM, Al-Mulhim FA, et al. Fatty infiltration of the liver in hospital practice. British Journal of Radiology, Vol. 65, 774-778, 1992.
• Ibrahim EM, Al-Idrissi HY, Al-Khadra A, et al. Ondansetron in the management of  emesis in patients receiving emetogenic chemotherapy. Cancer, Research, Therapy and Control, 3, 1-6, 1992.
• Al-Idrissi HY, Ibrahim EM, Qurashi NY. Breast cancer in low-risk population.                     International Journal of Cancer, 52, 48-51, 1992.
• Sadat Ali M, Yousuf A, Ibrahim EM, Al-Freihi H, Al-Muhanna F. Postmenopausal osteoporosis in Saudi Women: A pilot screening. Annals of Saudi Medicine, 13(3), 272-274, 1993.
• Al-Idrissi HY, Ibrahim EM, Sowayan SA, Al-Nabhan AA. Hodgkin's disease in adults in Saudi Arabia: Analysis of therapy outcome of combination chemotherapy only, for both localized and advanced disease. Cancer Research, Therapy and Control, 3, 127-136, 1993.
• Ibrahim EM, Al-Idrissi HY, Al-Khadra A, et al. Ondansetron in the management of emesis in patients receiving emetogenic chemotherapy. Cancer, Research, Therapy and Control, 3, 1-6, 1992.
• Al-Idrissi HY, Ibrahim EM, Hassan F, Al-Nabhan AA, Al-Khadra AH, Muhanna FA. A randomized, double-blind, crossover study of cilazapril and captopril in mild to moderately severe hypertension in Saudis. Journal of Drug Development, 5(4), 215-223, 1993.
• Al-Mulhim FA, Ibrahim EM, Sowayan SA, Wosornu L. An impact of decision analysis on the management of advanced hepatocellular carcinoma. Cancer Research, Therapy and Control, 3, 273-281, 1993.
•  Al-Muhanna FAA, Al-Ghassab GAA, Al-Rahman IS, Al-Qurain A,  Ibrahim EM, Malhotra KK, Al-Mohaya SA. Acute renal failure as seen in a hemolysis unit. Saudi Med Journal, 14(5), 432-435, 1993.
• Al-Quoran A, Satti MB, Al-Hamdan A, Al-Gindan Y, Ibrahim EM, Khatib R. Pattern of chronic liver disease in the Eastern Province of Saudi Arabia: A hospital-based clinicopathological study. Tropical and Geographical Medicine 14(5), 432-435, 1993.
• Al-Khadra A, Ladipo G, Hussain A, Ibrahim EM, Al-Gindan Y. In-hospital mortality of acute myocardial infarction in Saudi Arabia. Journal of the Saudi Heart Association 6(2), 123-127, 1994.
• Al-Mulhim F, Ibrahim EM. Magnetic resonance of the spine: an initial experience. Annals of Saudi Medicine 14(4), 333-337, 1994.
• Al-Bar AA, Ibrahim EM, Tamimi TM, Assuhaimi SA, Ibrahim AM. Hodgkin’s and non-Hodgkin’s lymphoma: Analysis of population-based data from the Eastern Province of Saudi Arabia. Saudi Medical Journal 15(4), 290-294, 1994.
• Al-Mulhim F, Ibrahim EM, El-Hassan AY, Moharram HM. Magnetic resonance imaging of tuberculous spondylitis. Spine 20(21), 2287-2292, 1995.
• Al-Quorain A, Ammar A, Al-Awami M, Hegazi M, El-Munshid HA, Ibrahim EM, Al-Muezen Y, Nassim F, Al-Gindan Y, Al-Freihi H. Comparison of intravenous famotidine and rantidine in suppressing gastric acid secretion in critically ill patients. Current Therapeutic Research 55(10): 1263-1270, 1994.
• Al-Sultan AI, Ibrahim EM. Factors influencing medical student’s career preferences. Journal of the Bahrain Medical Society 7(1): 7-12, 1995.
• Al-Mulhim FA, Ibrahim EM. Evaluation of students’ performance in diagnostic  radiology. Journal of the Bahrain Medical Society 17(1): 30-34, 1995.
• Tamimi TM, Al-Bar A, Al-Suhaimi S, Ibrahim EM, Ibrahim AW, Wosornu L, Gabriel GS. Lung cancer in the Eastern Region of Saudi Arabia: a population-based study. Annals of Saudi Medicine 16(1), 3-11, 1996.
• Ibrahim EM, Bynyan RF, Al-Nabhan AA, Al-Mulhim FA, Ibrahim RE. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. Acta Hematologica  96, (3), 126-134, 1996.
• Ibrahim EM, Nassim FM, Ibrahim R. Stimulation model for predicting survival in women receiving adjuvant therapy for early breast cancer.  The Cancer Journal from Scientific American 2(4), 234-240, 1996.
• Mohammed EE, Nur MA, Kurashi NY, Ibrahim EM, Ammar Kawakb. Survival after stroke in Saudis: a hospital based study. The Journal of Family and Community Medicine 3(1), 48-52, 1996.
• Al-Qurain A, Ibrahim EM,  Al-Sultan A. Diagnostic and therapeutic value of ERCP and prediction of outcome: a retrospective analysis. The Saudi Journal of Gastroenterology 2(3), 138-141, 1996.
• Al-Bar AA, Ibrahim EM, Al-Tamimi T, Assuhaimi SA, Ibrahim AW, Gabriel GS, Mishriky AM. Leukemia in the Eastern Region of Saudi Arabia: a population-based study (1987-1988). Annals of Saudi Medicine 16(5), 521-526, 1996.
• Ibrahim EM, Al-Mulhim FA. The effect of GM-CSF in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Medical Oncology, 14, 47-51, 1997.
• Al-Tamimi T, Ibrahim EM, Ibrahim AW, Al-Bar AA, Assuhaimi SA, Gabriel GS, Mishriky AM, Al-Idrissi HY, Al-Sohaibani MO, Al-Sibai MH. Cancer in the Eastrern Region of Saudi Arabia: a population-based study (1987-1988). Annals of Saudi Medicine 17(1), 53-66, 1997.
•  Al-Tamimi T, Ibrahim AW, Mishriky AM, Gabriel GS, Ibrahim EM, Al-Bar AA, Assuhaimi SA. Thyroid cancer in the Eastern Region of Saudi Arabia: a population-based study (1987-1988). Saudi Medical Journal 18(4), 374-380, 1997.
• Ibrahim EM.  Information superhighway……are we in the fast lane? (Editorial). Journal of Family and Community Medicine, 2(1), 9-10, 1995.
• Albar AA, Al-Tamimi TM, Ibrahim EM, Ibrahim A, et. al. Establishing a computerized tumor registry: the Eastern Province experience. Saudi Medical Journal 18(5), 488-491, 1997.
• Al-Mulhim FA, Ibrahim EM, Al-Nabhan AA, Ibrahim RE, Nassim FM, Ladipo GO. Clinical prediction rule for pulmonary infiltrates. Saudi Medical Journal, 19(3), 306-312, 1998.
• Ibrahim EM, Al-Mulhim FA. The effect of GM-CSF in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Biotherapy in Cancer, 2(3), 71-73, 1998. 91.     Ibrahim EM, Al-Mulhim FA, Al-Muhanna F, Al-Amri A. The effect of GM-CSF in chemotherapy-induced oral mucositis in non-neutropenic cancer patients. Journal of Family and Community Medical 5, 37-43, 1998.
• Ibrahim EM, Al-Mulhim FA, Al-Muhanna FA, Al-Amri A, Ezzat AA, Ajarim D, Stuart RK. Breast cancer: Data from the Eastern Province of Saudi Arabia. Medical Oncology 1998; 15(4), 241-247.
• Ezzat A, Ibrahim EM, Raja M, Al-Subhi S, Rostom A, Stuart RK. Locally advanced disease of the breast: high proportion of stage III disease in a young population. Medical Oncology, 16, 95-103, 1999.
• Ezzat A, Ibrahim EM, Stuart RK, Ajarim D, Bazarbashi S, El-Foudeh MO, Rahal M, Al-Sayed A, Berry J. Adding High-dose Tamoxifen to CHOP does not Influence Response or Survival in Aggressive Non-Hodgkin’s Lymphoma: an interim analysis of a randomized phase III Trial. Medical Oncology, 16, 1-8, 1999.
• Ibrahim EM, Stuart RK. Evidence-based medicine for the next millennium: Clinical appraisal and pragmatic approach. Saudi Medical Journal, 19: 295-296, 1999.
• Ibrahim EM, Ezzat A, Raja M, Rahal M, Ajarim DS, Mann B, Baloush A, Stuart RK, Bazarbashi SN. Primary gastric non-Hodgkin’s lymphoma: Clinical Features, Management, and Prognosis of 185 Patients with Diffuse Large B-Cell Lymphoma. Annal Oncol, 10: 1441-1449, 1999. (with Editorial: Gospodarowicz M. Individuality versus conformity: is perfection necessary in staging and prognostic classification of specific primary extranodal lymphomas? Annal Oncol, 10: 1405-1407, 1999.
• Rahal M, Bazarbashi S, El-Weshi A, Raja M, Pai C, El-Foudeh M, Al-Sayed A, Ezzat A, Ajarim D, Ibrahim E: Salvage chemotherapy for hodgkin's disease - a seven-drug containing regimen with and without stem cell transplant. Eur J Cancer 1999;35:1337.      
• Bazarbashi S, Raja MA, El Sayed A, Ezzat A, Ibrahim E, Kattan S, Kardar A, Peracha A, Lindstedt E, Hanash K. Prospective phase II trial of alternating intravesical Bacillus Calmette-Guerin (BCG) and interferon alpha IIE in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: Preliminary results. J Surg Oncol, 74 (3): 181-184 JUL 2000.
• Rahal MM, Ezzat AA, Ibrahim EM, Ajarim DS, Raja A, Stuart RK, Tulbah AM, Kandil A, Bazarbashi SN: Neoadjuvant high-dose sequential chemotherapy with adriamycin (a), paclitaxel (b), and cyclophosphamide (c) is feasible and effective in poor prognostic patients with locally advanced breast cancer (labc). Breast Cancer Research and Treatment 2000;64:71.
• Ibrahim EM, Ezzat A, Baloush A, Hussain ZH, Mohammed G. Pregnancy-associated breast cancer: a case-control-study. Med Oncol 17(4):293-300, 2000.
• Ibrahim EM, Ezzat A, Amr N El-Weshi, Justin M Martin, Yasser M Khafaga, Wesal Al Rabih, Dahish S Ajarim, Mahoud O Al-Foudah, Emanuele Zucca. Primary Intestinal Diffuse Large B-Cell Non-Hodgkin’s Lymphoma: Clinical Features, Management, and Prognosis of 66 Patients. Annals of Oncology, 12: 53-58, 2001.
• Adnan A. Ezzat, Ibrahim EM, Amr N El Weshi, Yasser M Khafaga, Mahmmoud Al-Jurf, Justin M Martin, Dahish S Ajarim, Shouki N Bazarbashi, Emanuele Zucca, Robert K Stuart. Localized Non-Hodgkin’s Lymphoma of the Waldeyer’s Ring: Clinical Features, Management, and Prognosis of 109 Adults Patients with Diffuse Large-B Cell. Head and Neck 23: 547-558, 2001.
• Ezzat AA, Ibrahim EM, Dahish S Ajarim, Mohammed M Rahal, Madras M Raja, Robert K Stuart, Asma M Tulbah, Alaa Kandil, Osama A Al-Malik, Shouki  N Bazarbashi. High Complete Pathological Response in Locally Advanced Breast Cancer using Paclitaxel and Cisplatin. Breast Cancer Research and Treatment 62: 237-244, 2000.
• Ezzat AA, Ibrahim EM. High-dose chemotherapy and autologus bone marrow transplantation have no benefit over standard chemotherapy for aggressive non-Hodgkin’s lymphoma. Evidence-Based Oncology 2: 98-100, 2001 (editorial).
• El-Weshi A, Khafaja Y, Allam A, Mosseri V, Ibrahim EM, El-Serafi M, El-Badawi S. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfraction in stage III and IV nasopharyngeal carcinoma. Acta Oncologica 40, 574-581, 2001.
• Tulba A, Ibrahim EM, Ezzat A, et. al. HER-2 does not predict response to neoadjuvant chemotherapy or prognisticate survival in patients with locally advanced breast cancer. Med Oncol 19,  15-23, 2002.
• Baslaim MM, Al Malik OA, Al Sobhi SS, Ibrahim EM, Ezzat A, Ajarim D, Tulbah A, Chaudhary MA, Sorbis RA. Decreased axillary lymph node retrival in patients after neoadjuvant chemotherapy. A J Surg 184, 299-301, 2002.
• Al-Jurf M, Quaideh T, Ezzat A, Ibrahim EM, Tabkhi A. Antigen and/or immune-driven  immunoproliferative disorders. Annal Oncol 14, 1595-1606, 2003.
• Ibrahim EM, Al-Saad R, Wishi A, et. al. Appraisal of communication skills and patients’ satisfaction in cross-language encounters in oncology practice. Cancer Education 17: 216-221, 2002.
• Ibrahim EM, Ezzat A, Rahal M, Raja M, Ajarim D. Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia. Medical Oncology 2005;22(4):343-52
• Adnan A Ezzat, Ezzeldin M Ibrahim, Dahish S Ajarim, Mohammed M Rahal, Madras M Raja, Robert K Stuart, Asma M Tulbah, Alaa Kandil, Osama A Al-Malik, Shouki  N Bazarbashi. High Complete Pathological Response in Locally Advanced Breast Cancer using Paclitaxel and Cisplatin. Breast Cancer Research and Treatment 62: 237-244, 2000.
• Ezzat A, Ibrahim EM, Ajarim D, et. al. Phase II study of paclitaxel and cisplatin in locally advanced breast acncer. Analysis of 126 patients. British Journal of Cancer 90: 968-74, 2004.
• Ibrahim EM, Ezzat A. Failure of the International Prognostic Index to prognosticate outcome in primary gastric DLBC lymphoma. Ann Oncol. 2004 May;15(5):841; author reply 842.
• Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim EM, et. al. Second allogenic bone marrow transplantation after myeloablative conditioning: analysis of 45 cases from single institution. Hematology 9: 123-129, 2004.
• Ibrahim EM, Ezzat AA, Rahal MM, Raja MM, Ajarim DS. Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia. Medical Oncology 22 (4): 343-352, 2005.
• Ibrahim EM, Fawzy EE, Al-Maghraby J, Kanaan H, Radwi AN, Bahadur YA. Her-2/neu receptor status and non-small cell lung cancer: is there any prognostic correlation? Kasr-el-Aini Journal of Clinical Oncology and Nuclear Medicine 1 (2), 2005.
• Ibrahim EM, Boulos MK. Access to online information by adult Saudi cancer patients. Journal of Health Conusumers of the Internet 10 (4), 2006.
• Ibrahim EM, Zeeneldin A, Al-Gahmi A, Sallam Y, Fawzi E, Bahadur Y. Safety and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic colorectal cancer. Indian Journal of Cancer, 44(20), 2007.
• Ibrahim EM, Bin Sadek B, Zeeneldin A, Ezzat A. The Present and the Future of Breast Cancer Burden in the Kingdom of Saudi Arabia. Med Oncol 25:387-393, 2008.
• Ibrahim EM, Zeeneldin AA, El-Khodary TR, Al-Gahmi AM, Bin Sadiq BM. Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol 2008;14.
• Ibrahim EM, Bakr M. Bin Sadiq, Laila Banjar, Saeed Awadalla, Mohammed S. Abomelha. Current and Future Cancer Burden in Saudi Arabia: Meeting the Challenge. Hematol Oncol Stem Cel Ther 2008; 1(4): 210-215.
• Ibrahim EM, Al-Gahmi AM, Zeenelin AA, Zekri JM, Elkhodary TR, Gaballa HE, Fawzy. EE, El Sayed ME, Alzahrani MS. Basal vs. Luminal A Breast Cancer Subtypes: A Matched Case-Control Study Using Estrogen Receptor, Progesterone Receptor, and HER-2 as Surrogate Markers. Med Oncol 2009; 26:372–378
• Ibrahim EM, Zekri J. Folic Acid Supplementation for the Prevention of Recurrence of Colorectal Adenomas: Metaanalysis of Interventional Trials. Med Oncology 2009 (available online as early release).
• Ibrahim EM,  Aboelkhair M. Al-Gahmi, Jamal M. Zekri,  Said S. Awadalla, Tawfik R. Elkhodary, Ehab E. Fawzy, Yasir A. Bahadur, Mohamed E. Elsayed, Ahmed A. Zeeneldin, Raha H. Al-Ahmadi, Ayman H. Linjawi. Preoperative Systemic Therapy in Locally Advanced  Breast Cancer: A Single Institution Experience. Ecancermedicalscience 2009, Volume: 3 Article Number: 161 DOI: 10.3332/ecancer.2009.161 Received: 30/09/2009 16:04:21 Published: 12/10/2009.
• Zekri JM, Ibrahim EM, A. M. Al-Gahmi1, A. A. Zeeneldin, T. R. Elkhodary, H. E. Gaballa, E. E. Fawzy, M. E Elsaye, Y. Bahadur, S. Awadalla, M. S. Alzahran, B. Ben Sadiq.  A Matched Case-control Study of Triple Negative vs. HER-2 Positive (irrespective of hormonal status) Breast Cancer: Two Subtypes with High Risk Features and Poor Outcome. The Gulf Journal of Oncology, 7, 1-84, 2009 ( http://www.gffcc.org/journal/art2-vii.htm).
• Ibrahim EM, J. Zekri, Bin Sadiq B. Cetuximab-Based Therapy for Metastatic Colorectal Cancer: A Meta-analysis of the Effect of K-ras Mutations. International Journal of Colorectal Disease, Jun;25(6):713-21, 2010.
• Ibrahim EM, Zekri JM, Abdelrahman H. Adjuvant Platinum-Based Chemotherapy versus Observation in Non-Small Cell Lung Cancer: Meta-analysis of Trials with Intermediate- and Long-Term Follow-up. The Open Lung Cancer Journal (Accepted for Publication).
• Ibrahim EM. Frontline gefitinib in advanced nonsmall cell lung cancer: Meta-analysis of published randomized trials. Annals of Thoracic Medicine, Vol 5, Issue 3, July-September, 153-160, 2010.
• Zekri J, Rizvi SA, Ibrahim E. Lapatinib and capecitabine in women with advanced/metastatic HER2+ breast cancer: single center experience. The Oncologisit, Abstract # 10, p19, 2010.
• Boulos DN, Ghali RR, Ibrahim EM, Boulos MN, Abdelmalik P. An eight-year snapshot of geospatial cancer research (2002-2009): clinico-epidemiological and methodological findings and trends. Med Oncol. 2010 Jun 30. 
• Ibrahim EM, Abouelkhair KM. Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials. Med Oncol. 2011 Jan 9.
• Ibrahim EM, Abouelkhair KM, Al-Masri OA, Chaudry NC, Kazkaz GA. Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials. Lung. 2011 Mar 20. [Epub ahead of print] PubMed PMID: 21424607.
• Ibrahim, E.M. and A. Al-Homaidh, Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol, 2011. 28(3): p. 753-65.

PAPERS PUBLISHED IN PROCEEDINGS & PRESENTED AT SCIENTIFIC CONFERENCES

• Ragaz J, Ibrahim EM, Leahy M, Willan A. Some observations on hormonal therapy of metastatic breast cancer: Aminoglutethiamide with and without tamoxifen. Proceedings of American Society of Clinical Oncology; Washington, DC, USA, Vol. 22, C-452, 448, 1981.
• Ragaz J, Ibrahim EM, Leahy M, Willan A. A combination of hormones for metastatic breast cancer: Aminoglutethiamide and tamoxifen. Proceedings American Association for Cancer Research; Washington, DC, USA, Vol. 22, 575, 145, 1981.
• Ragaz J, Leahy M, Ibrahim EM, Spinelli J. Hormonal treatment of metastatic breast cancer: Medical adrenalectomy with Aminoglutethiamide and tamoxifen.Proceedings Clinical and Investigative Medicine; Montreal, Canada, Vol. 2, 23 B, 1981.
• Ragaz J, Leahy M , Ibrahim EM, Spinelli J, Godolphin WJP. Hormonal treatment of metastatic breast cancer. Proceedings of New Prospective for Breast Cancer;Pennsylvania, USA, P-l 3, 1981.
• Ragaz J, Ibrahim EM, Leahy M, Spinelli J, Willan AR. Medical adrenalectomy with aminoglutethiamide and tamoxifen for metastatic breast cancer: Effects on response and pituitary hormones. Proceedings American Association for Clinical Research; St. Louis, Missouri, USA, Vol. 23, 571, 145, 1982.
• Ibrahim EM, Ragaz J, Leahy M. Combination of hormones for the management of metastatic breast cancer: Tamoxifen vs. aminoglutethiamide vs.tamoxifen and aminoglutethiamide. Proceedings of the Seventh Saudi Medical Meeting; Dammam, Saudi Arabia, 31, 1982 (abstract).
• Ibrahim EM, Ragaz J, Leahy M. Combination of hormones for the management of metastatic breast cancer: Tamoxifen vs. aminoglutethiamide vs.tamoxifen and aminoglutethiamide. Proceedings of the Seventh Saudi Medical Meeting;  Dammam, Saudi Arabia, 104-l 09, 1982 (full text).
• Ibrahim EM, Ragaz J, Leahy M, Spinelli J. Medical adrenalectomy for metastatic breast cancer. Proceedings of the Recent Advances in the Management of Breast Cancer; Istanbul, Turkey, 1983.
• Ibrahim EM, Mitry N, Al-Idrissi HY, Ibrahim AW. Structure and objectives of the tumor registry of the Eastern province. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, 164, 1983.
• Tamimi TM, Ibrahim EM, Al-Idrissi HY, Ibrahim AW, Mitry NF, Al-Sohamy S, Al-Bar A. Computerized tumor registry of the Eastern Province. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia (full text) 496-497, 1983.
• Al-Idrissi HY, Ibrahim EM, Ibrahim AW, Isa AM. Parity in immunology. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, 272, 1983.
• Al-Idrissi HY, Ibrahim EM, Ibrahim AW, Isa AM. Parity in immunology. Proceedings of the Eighth Saudi Medical Conference; Riyadh, Saudi Arabia, (full text) 575-576, 1983.
• Al-Breiki H, Mitry NF, Khawaja S, Al-Arfaj A, Pirnar T, Ibrahim EM. The value of computerized tomography scan in diagnosis of abdominal  masses. Proceedings of the Eight Saudi Medical Conference; Riyadh, Saudi Arabia, 81 , 1983.
• Mitry N F, Taha S, Pirnar T, Ibrahim EM, Al-Idrissi HY. The value of computerized tomography in urology. Proceedings of the Joint Meeting of the Royal College of Surgeons of Edinburgh; Singapore, 1984.
• Ibrahim EM, Satti MB, Abdelsatir A, Al-Idrissi HY. The pattern of malignant Iymphoma in the Eastern Province of Saudi Arabia. Proceedings of Second International Conference on Malignant Lymphoma; Lugano, Switzerland 118, 1984.
• Ibrahim EM, Al-Qurain A, Magbool G, Satti MB, Higazzy M, Al-Qurain A, Satti M, Al-Idrissi HY. Head and neck cancer in Arabia: the role of "Al shamma". Proceedings of the 6th International Symposium on Prevention and Detection of Cancer; Vienna, Austria, (10:103), 432, 1984.
• Ibrahim EM, Al-Qurain A, Magbool G, Satti M, Higgazy M, Al-Idrissi HY. Head and neck cancer in Arabia: the role of Alshamma. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 327, pp 88, 1985.
• Al-Idrissi HY, Al-Qurain A, Ibrahim EM, Magbool G, Satti MB, Hegazi M. Head and neck cancer in Arabia: the role of "Alqat". Proceedings of the 6th International Symposium on Prevention and Detection of Cancer; Vienna, Austria, (18:102), 431 , 1984.
• Al-Idrissi HY, Satti MB, Ibrahim EM, Magbool G, Al-Qurain A, Higazzy M. Head and neck cancer in Arabia: the role of Alqat. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 328, 1985.
• Ragaz J, Ibrahim EM, Leahy M, Spinelli J. Aminoglutethiamide (AG) and tamoxifen (T) in combination versus T in metastatic breast cancer: 6 years update. Proceedings of the American Society of Clinical Oncology; USA, Vol. 3, C-465, 
• Ibrahim EM, Al-Idrissi HY, Satti MB, Abdel Satir, Ghani A. Alternating non-cross resistant chemotherapy for advanced breast cancer. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 631, 1985.
• Mitry NF, Ibrahim EM, Yourself A, Taha S, Al-Idrissi HY. The value of CT in staging Hodgkin's and non-Hodgkin's lymphoma and its role in assessment of  therapy outcome. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 744, 1985.
• Ibrahim EM, Al-Idrissi HY, Satti MB, Al-Qurain A, Satir A, Ghani, Boukhary H. Combination chemotherapy alone for localized and advanced non-Hodgkin's lymphoma. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 755, 1985.
• Al-Idrissi HY, Ibrahim EM, Al-Qurain A, Satti M, Satir A, Ghani A. Primary        hepatocellular carcinoma in the Eastern Province of Saudi Arabia. Proceedings of the 3rd European Conference on Clinical Oncology; Stockholm, Sweden, 395, 1985.
• Ibrahim EM. The use of systemic chemotherapy in the management of advanced breast cancer. Proceedings of the Symposium, Cancer in Saudi Arabia; pp 39, Riyadh, Saudi Arabia, 1986.
• Ibrahim EM, Al-Idrissi HY, Ibrahim AW, Dossary 1, Al-Jammaa A, Al-Ethan S. The antiemetic efficacy of high-dose dexamethasone therapy in patients receiving chemotherapy. Proceedings of the international Symposium on the Immunobiology of Cancer, Published in Cancer Detection and Prevention Vol. 8 (516), 14: 096, Copenhagen, Denmark, 1985.
• Al-Qurain A, Al-Idrissi HY, Ibrahim EM, Satti Mb, Al-Freihi H, Al-Mohaya S,  Al-Dossary J, Abdel Hadi M. Esophageal cancer in the Eastern Province of Saudi Arabia: Analysis of therapy and etiology. Proceedings of the international Symposium on the Immunobiology of Cancer, Published in Cancer Detection and Prevention Vol. 8 (516), 14:091, Copenhagen, Denmark, 1985.
• Al-Idrissi HY, Ibrahim EM, Al-Qurain A, Satti Mb, Al-Dossary J, Abdel Hadi. The pattern of gastrointestinal tract malignancies in Saudi Arabia. Proceedings of the International Symposium on Immunobiology of cancer; Published in Cancer Detection and Prevention Vol. 8 (516), 14: 092, Copenhagen, Denmark, 1985.
• Al-Nahdy M, Ibrahim EM. Pattern of allergy in a Saudi population. Proceedings of the Annual Meeting of the European Academy of Allergology and Clinical Immunology; F-33, pp 66, Copenhagen, Denmark, 1988.
• Ibrahim EM, Al-Idrissi HV, Al-Khattii AA, Al-Faraj AA, Al-Khatib RI, Kharouf JA. Piperacillin combined with aminoglycoside for empirical therapy of febrile granulocytopenic cancer patients. Hospital Acquired Infections and Antibiotic Policies Into the 90's; Royal College of Physician, London, United Kingdom, 1989.
• Ibrahim EM, Al-Idrissi HY, Ahmad K, Ababtain W, Boukhary. Antiemetics for patients receiving anticancer therapy. Proceedings of the 5th Mediterranean Congress of Chemotherapy; O 71, 200, Cairo, 1986.
• Ibrahim EM, Al-Idrissi HY. Breast cancer in low-risk population: the influence of age and menstrual status on disease pattern and survival. Proceedings of the 15th International Cancer Congress (UICC), Hamburg, West Germany, 1990(25.23.04).
• Al-Idrissi HY, Ibrahim EM. Hodgkin's disease in adult in Saudi Arabia. Proceedings of the 15th International Cancer Congress (UICC), Hamburg, West Germany, 1990(25.23.07).
• Chirayath H, Ibrahim EM, Kurashi NY. Stroke in Qassim area of Saudi Arabia. Proceedings of the Asian and Oceanian Congress of Neurology, Tokyo, Japan, 1991(0-l0-04).
• Sadat Ali M, Ibrahim EM. Malignant bone tumors in pregnancy. Proceedings published in the Annals of Saudi Medicine, 1992.
• Ibrahim EM, Ajaram D, Wiseibky R, Al-Idrissi HY. A multicenter trial on the use of r-HuEpo in the management of cancer-related anemia. The International Working Group on the Management of Cancer-Related Anemia using r-HuEpo, Lucerne, Switzerland.
• Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the American Society of Clinical Oncology, 1994 (Abstract No. 129).
• Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the Saudi International Oncology Conference, Riyadh 1994.
• Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the International Cancer Congress, National Cancer Institute, Cairo 1994.
• Ibrahim EM, Nassim F. M. An expert system for the prediction of life expectancy in patients receiving adjuvant therapy for early breast cancer. Proceeding of the International Symposium on Computer and Health Information, Riyadh, Saudi Arabia, 1995.
• Ibrahim EM, Al-Idrissi HY, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. 1996 The First Pan Arab Cancer Conference and the Fourth Egyptian-French Cancer Congress, Cairo, Egypt, 1996.
• Ibrahim EM, Al-Idrissi HY, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA, Ibrahim RE. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. The 26th Congress of the International Society of Hematology, Singapore, August, 1996.
• Ibrahim EM, Bunyan RF, Al-Mulhim FA, Al-Nabhan AA, Ibrahim RE. Chemotherapy with MECOP-B for intermediate-grade and high-grade non-Hodgkin’s lymphoma in Saudi Arabia: Clinical results and analysis of prognostic factors. The European Society for Medical Oncology (21st ESMO Congress), Vienna, Austria, 1996.
• Ibrahim EM. The concepts and limitations of meta-analysis: Lessons from the early breast cancer adjuvant trials. The International Conference on Cancer, Riyadh, Saudi Arabia, 1996.
• Ibrahim EM. The effect of G-CSF and GM-CSF on chemotherapy-related oral mucositis. The Second Middle East Symposium on Hematopoietic Growth Factors, Dubai, United Arab Emirates, 1996.
• Ibrahim EM. Screening for colorectal cancer: Examining the perplexity. The Fifth Meeting of the Saudi Gastroenterology Society, Al-Khobar Saudi Arabia, 1997.
• Ibrahim EM, Al-Mulhim. Use of granulocyte-macrophage colony stimulating factor in chemotherapy induced oral mucositis in non-neutropenic cancer patients. Supportive Care in Cancer, San Antonio, Texas, March 14-17, 1998.
• Ibrahim EM, Al-Mulhim. Use of granulocyte-macrophage colony stimulating factor in chemotherapy induced oral mucositis in non-neutropenic cancer patients. American Society of Clinical Oncology, Los Angles, California, USA, May 16-17, 1998 (poster presentation, abstract # 335).
• Ibrahim EM, Adnan A. Ezzat, Robert K. Stuart, Dahish S. Ajarim, Madras Raja;Stage III Breast Cancer: Single Institution Experience American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract 360).
• Madras A. Raja, Adnan A. Ezzat, Ibrahim EM, Shouki Bazarbashi, Mohamed Rahal, Robert K. Stuart. Prospective Comparative Study of 5HT-3 Antagonists in Moderately Emetogenic Chemotherapy. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #2334).
• Shouki Bazarbashi, Madras A. Raja, Adnan Ezzat, Said Kattan, Eric Lindstedt, Amjad eracha, Abdul H. Kardar, Talal Merdad, Chandrashekhar Pai, Mohammed Rahal, Adher Al-Sayed, Ibrahim EM, Kamal Hanash. Prospective Phase II Trial of Alternating Intravesical BCG and Interferon a-2b (IFN) in Superficial Transitional Cell Carcinoma (TCC) of the Urinary Bladder. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract # 1289).
• Robert Stuart, Adnan Ezzat, Ibrahim EM, Mohammed Ranginwala, Dahish Ajarim, Mahmmoud El-Foudeh, Madras Raja, Shouki Bazarbashi, Mohammed Rahal. CHOP vs. CHOP+High-Dose Tamoxifen in the Management of Aggressive Non-Hodgkin's Lymphoma: Interim Analysis of a Prospective, Randomized Trial. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #141).
• Mohammed Rahal, Adnan A. Ezzat, John Berry, Madras A. Raja, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim, Ibrahim EM. Chronic Administration of Etoposide (VP16) Followed by CNOP (Cyclophosphamide, Novantrone, Oncovin and Prednisone) in Elderly Patients (PTS) with Aggressive Non-Hodgkin's Lymphoma. American Society of Clinical Oncology, Atlanta, Georgia, May 13-18, 1999 (Abstract #127).
• Adnan Ezzat, Ibrahim EM, Mohammed Ranginwala, Dahish Ajarim, Mahmmoud El-Foudeh, Madras Raja, Shouki Bazarbashi, Mohammed Rahal, Stuart RK. CHOP vs. CHOP+High-Dose Tamoxifen in the Management of Aggressive Non-Hodgkin's Lymphoma: Interim Analysis of a Prospective, Randomized Trial. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.
• Bazarbashi Shouki, Mohammaed Rahal, Adnan A. Ezzat, John Berry, Madras A. Raja, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim, Ibrahim EM. Chronic Administration of Etoposide (VP16) Followed by CNOP (Cyclophosphamide, Novantrone, Oncovin and Prednisone) in Elderly Patients (PTS) with Aggressive Non-Hodgkin's Lymphoma. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.
• Madras A Raja, Adnan A. Ezzat, Ibrahim EM, Shouki Bazarbashi, Robert K. Stuart, Dahish Ajarim. Comparative study of non-Hodgkin’s Lymphoma between Saudi Arabia and USA. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.
• Ibrahim EM, Ezzat A, Raja M, Rahal M, Ajarim D, Mann B, Baloush A, Stuart RK, Bazarbashi S. Primary gastric non-Hodgkin’s lymphoma: Clinical Features, Management, and Prognosis of 185 Patients with Diffuse Large B-Cell Lymphoma. American Society of Clinical Oncology-Panarab Meeting, Cairo, Egypt November 8-11, 1999.
• Ibrahim EM, Adnan A Ezzat, Madras M Raja, Mohammed M Rahal, Dahish S Ajarim, Bhuupinder Mann, Abed Baloush, Robert K Stuart, Shouki N Bazarbashi. PRIMARY LARGE-B CELL GASTRIC (LBCL) NON-HODGKIN'S LYMPHOMA: ANALYSIS OF 185 PATIENTS.  King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 127).
• Shouki Bazarbashi, Mohammed Rahal, Madras Raja, Mahmoud El Foudeh, Amer El Weshi, Adnan Ezzat, Dahish Ajarim, Ibrahim EM. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. CONVENTIONAL VERSUS HIGH DOSE CHEMOTHERAPY (HDC) FOLLOWED BY HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR RELAPSED OR REFRACTORY HODGKIN'S DISEASE. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 150).
• Muhammad Memon, Amer El-Weshi, Shouki Bazarbashi, Adnan Ezzat, Ibrahim EM, Mohammed Rahal, Madras Raja. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. ETOPOSIDE/IFOSFAMIDE/CISPLATIN (VIP) IN THE TREATMENT OF EWING'S SARCOMA UNRESPONSIVE TO STANDARD THERAPY. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 2218).
• Amr N El-Weshi, Ibrahim EM, Adnan A Ezzat, Yasser Khafaga, Madras Raja, Shouki Bazarbashi, Dahish S Ajarim, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. LOCALIZED PRIMARY NASOPHARYNGEAL NON-HODGKIN'S LYMPHOMA (PNP-NHL): SINGLE CENTER EXPERIENCE WITH 47 PATIENTS. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 132).
• Dahish Ajarim, Ibrahim EM, Adnan A Ezzat, Abed Baloush, Zeinab H Hussain. King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. PREGNANCY-ASSOCIATED BREAST CANCER: CASE-CONTROL STUDY. American Society of Clinical Oncology, New Orleans, Louisiana, May 20-23, 2000 (Abstract 518).
• Adnan A Ezzat, Ibrahim EM, Dahish S Ajarim, Mohammed M Rahal, Madras M Raja, Robert K Stuart, Asma M Tulbah, Alaa Kandil, Osama A Al-Malik, Shouki  N Bazarbashi. High Complete Pathological Response in Locally Advanced Breast Cancer using Paclitaxel and Cisplatin. The 23rd San Antonio Breast Conference, San Antonio, Texas, December 6-9, 2000.
• Rahal MM, Ezzat AA, Ibrahim EM, Ajarim DS, Raja A, Stuart RK, Tulbah AM, Kandil A, Bazarbashi SN. Neoadjuvant high-dose Sequential Chemotherapy with Adriamycin (A), Paclitaxel (P), and Cyclophosphamide is Feasible and Effective in Poor Prognostic Patients with Locally Advanced Breast Cancer (LABC). The 23rd San Antonio Breast Conference, San Antonio, Texas, December 6-9, 2000.
• Ibrahim EM.Early Breast Cancer. Pathology of the Breast, KFSH & RC, Jeddah, January 2001, Saudi Arabia.
• Ibrahim EM. Primary Intestinal Non-Hodgkin’s Lymphoma, Update in Hematology, January 2001, Jeddah, Saudi Arabia.
• D Ajarim, M El Foudeh, Y Khafaga, A Bajouda, A Ezzat, Ibrahim EM, S Bazarbashi, M Raja, M Rahal, C Pai, A El Weshi, A Baloush. Primary Non-Hodgkin’s Lymphoma of Bone in Adults. American Society of Clinical Oncology, San Francisco, California 12-19, 2001 (Abstract 2674).
• Ibrahim EM, Adnan Ezzat, Amr El Weishi, Justin Martin, Yasser Khafaga, Dahish Ajarim, Mahmoud El Foudah, Emanuele Zucca. Primary Intestinal Diffuse Large B-Cell Non-Hodgkin’s Lymphoma: Clinical Features, Management, and Prognosis of 66 Patients. American Society of Clinical Oncology, San Francisco, California 12-16, 2001 (Abstract 1182).
• Baslaim MM, Ibrahim EM, Al-Malik O, Al-Sobhi SS, Ezzat A, Ajarim D, Tulbah A, ChaudharyMA. Decreased axillary lymph node  retrival after neoadjuvant chemotherapy in patients with locally advanced breast cancer. The 7th Annual Multidisciplinary Symposium on Breast Disease, Ame Island, Florida (2002).
• Baslaim MM, Ibrahim EM, Al-Malik O, Al-Sobhi SS, Ezzat A, Ajarim D, Tulbah A, ChaudharyMA. Decreased axillary lymph node  retrival after neoadjuvant chemotherapy in patients with locally advanced breast cancer. The 3rd Annual American Society of Breast Surgeons, Boston, MA (2002).
• Ibrahim EM. The importance of Clinical Trials. Clinical Trials: Ethical Issues, Jeddah, Saudi Arabia (2005)
• Ibrahim EM. Saudi Experience, Update on Oncology, Cape Town, South Africa (2005)
• Ibrahim EM. Bronchogenic Carcinoma: What is beyound Surgery, Saudi Cancer Society and the Arab Thoracic Association, Jeddah, Saudi Arabia (2005)
• Ibrahim EM. Breast Cancer Screening, Women Health Update, Jeddah, Saudi Arabia (2006)
• Ibrahim EM. Writing Results and Discussion, Writing Biomedical Research Paper, Jeddah, Saudi Arabia (2006)
• Ibrahim EM. Interactive Computer Applications on Biostatistics, Jeddah, Saudi Arabia (2006)
• Ibrahim EM. Basics of Biostatistics, Biostatistics Course, Jeddah, Saudi Arabia (2006) 75.    Ibrahim EM. Intoduction to Healthinformatics, Jeddah, Saudi Arabia (2006)
• Ibrahim EM. Informed Consent, Clinical Trials: Ethical Issues, Jeddah, Saudi Arabia (2006)
• Ibrahim EM. Complimentry and Alternative Medicine: The Evidence for Evidence, Early Breast Cancer Conference, Jeddah, Saudi Arabia (2007)
• Ibrahim EM. Angiogenesis in Metastatic Breast Cancer, Oncology Update, Cairo, Egypt (2007)
• Ibrahim EM. Role of Primary Physicians in Oncology Practice, Jeddah, Saudi Arabia (2007)
• Ibrahim EM. Breast Cancer, The Best of the Decade, Jeddah, Saudi Arabia (2008)
• Ibrahim EM. A. M. Zeeneldin, B. Bin Sadiq. The present and the future of breast cancer burden in the Kingdom of Saudi  Arabia. J Clin Oncol 26: 2008 (May 20 suppl; abstr 22089)
• Ibrahim EM. Liptomeningeal carcinomatossis: Unusual Presentation. GSK sponsored meeting, St Gallen, Switzerland (2009).
• Ibrahim EM. Cetuximab in Metastatic Colorectal Cancer: Meta-analysis of Efficacy Based on K-Ras Mutations Status. Beirut, Lebanon (2010).

EDITED BOOKS & CHAPTERS IN BOOKS

• El-Mawla NG, Ibrahim EM, El-Serafy M. The use of systemic chemotherapy in the management of advanced breast cancer. In: Breast Cancer: A Comprehensive Approach (1st Edition), Eds. Omer S, Contesso G, 161-l69, 1984. The book was published by the Cairo Medical Syndicate Scientific Committee and supported by the Egyptian Ministry of Health and the Egyptian Academy of Scientific Research and Technology. The book was written  by several experts in breast cancer disease: pathologists, surgeons, medical oncologists, radiotherapists, and epidemiologists from Saudi Arabia, Egypt, France (Gustave-Roussy Institute), USA (The American Cancer Society). It addresses various aspects of breast cancer.
• Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In: Breast Cancer (2nd Edition), Eds. Omer S, Contesso G, 126-131, 1987. The book was published by Korba, London. The book was written with contribution from authors from Egypt, France, USA and Saudi Arabia to provide an updated experience of all controversial issues in the diagnosis and management of breast cancer. 
• Ibrahim EM. The editor of book titled "Comprehensive Approach to Clinical Examination". It contained 15 chapters in 535 pages. The book is designed in a way that should make understanding, learning and studying easier. In preparing it, many standard textbooks and monographs have been reviewed. The book contained many illustrations of key examination techniques, graphs, and easily understood tables of important facts; its style was intended to capture the reader's interest and imagination. Though several chapters were written by different contributors, a unified format is maintained throughout. I believe that this book was able to satisfy the need for a clear guide to clinical medicine, and it has certainly competed favorably with similar books in this respect, nevertheless, it was never predestined to serve as an extensive textbook in theoretical medicine. Although a chapter was devoted to common symptoms, the cardinal symptoms of organ systems were reinforced under the appropriate chapters. Some of the commoner and more important diseases have been covered in a simplified way. Moreover, a chapter that introduces the readers to the basis of radiological investigations; and another dedicated to illustrate the basic principles of electrocardiography, were included.  The two chapters are added to ensure a quick basic understanding of these important investigations. A third chapter was also added to promote the philosophy of medical informatics. Neither, pediatric nor gynecological examination were discussed. 
• Ibrahim EM. The editor of a new book “Comprehensive Approach to Case Studies in Medicine”. The book addressed a novel approach to problem-oriented clinical medicine. It contained 40 chapters with contributions from several faculty staff at King Faisal University and consultants at King Faisal Specialist Hospital. The book came in 239 pages.
• Ibrahim EM, El-Serafy M. Chemotherapy in the management of metastatic breast cancer. In: Breast Cancer (3rd edition), Eds. Omer S, Contesso G, 137-142, 1997. The book was published by the Association Medicale Franco Egyptienne.
• Ibrahim EM, Asma Tulbah. Basic Principles of Tumor Pathology and Biology. In: Basic Principles of Nuclear Medicine (1st edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York, 2001, p 169-178.
• El-Gazzar, Ibrahim EM. Nuclear Medicine Basis of Bone Tumors. In: Basic Principles of Nuclear Medicine (1st edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York.
• Ibrahim EM. In: Textbook of Tropical Surgery. Eds. Refaat Kamel and John Lumley, Westminister Publishing Ltd., London, 2004, Chapter 70. 
• Ibrahim EM, Al-Maghrabi  J A. Basis of Tumor Imaging 1: Principles of Tumor Pathology and Biology. In: Basic Principles of Nuclear Medicine (2nd edition), Eds. Abdelhamid El-Gazzar, Springer-Verlarg, New York, 2006, p  264-277.
• Ibrahim EM, Ezzat AA. Cancer Control in Asia Pacific – Saudi Arabia